Clinical Trials Directory

Trials / Completed

CompletedNCT04506216

Eating Disorders in Type 1 Insulin-dependent Diabetes Patients

Prevalence of Eating Disorders in Adult Patients With Type I Diabetes and Insulin Pump Treatment

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
200 (actual)
Sponsor
Icadom · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine the prevalence of eating disorders in type 1 insulin-dependent diabetes patients

Detailed description

The risk of developing an eating disorder is increased in type 1 diabetes patients and associated with a poor prognosis in terms of glycemic control, metabolic complications, degenerative complications, and mortality. Therefore the terminology diaboulimia has emerged to characterize an eating disorder specific to type 1 insulin-dependent diabetes patients, with insulin under dosage with a view of losing or controlling weight and that can contribute to a deterioration of the body composition. The purpose of this study is to determine the prevalence of eating disorders in an adult cohort with type 1 insulin-dependent diabetes.

Conditions

Interventions

TypeNameDescription
OTHERcohortDuring a regular follow-up visit, the following data will be collected: * questionnaires on lifestyle, eating custom (SCOFF-F, 5th question of the m-SCOFF) and physical activity (IPAQ) * bio-electric impedance analysis * insulin pump and sensor data collection

Timeline

Start date
2020-09-01
Primary completion
2021-12-23
Completion
2021-12-23
First posted
2020-08-10
Last updated
2022-04-08

Locations

1 site across 1 country: France

Source: ClinicalTrials.gov record NCT04506216. Inclusion in this directory is not an endorsement.

Eating Disorders in Type 1 Insulin-dependent Diabetes Patients (NCT04506216) · Clinical Trials Directory